Xiaobing Wang

Polygenic Risk Scores have high diagnostic capacity in ankylosing spondylitis

Zhixiu Li, Paul Leo, Erika de Guzman et al. · Annals of the Rheumatic Diseases · 2021 · 85 citations · Full text

Characteristic dysbiosis in gout and the impact of a uric acid-lowering treatment, febuxostat on the gut microbiota

Suxian Lin, Tao Zhang, Lingxiao Zhu et al. · Journal of genetics and genomics/Journal of Genetics and Genomics · 2021 · 50 citations

Uric Acid-lowering Treatment, Probiotic, Urology +12

Microbiota dysbiosis in primary Sjögren’s syndrome and the ameliorative effect of hydroxychloroquine

Xiaobing Wang, Kun Pang, Jinfeng Wang et al. · Cell Reports · 2022 · 44 citations · Full text

Dysbiosis, Immunology, Human Microbial Flora +21

Asiaticoside might attenuate bleomycin‐induced pulmonary fibrosis by activating cAMP and Rap1 signalling pathway assisted by A2AR

Jing Luo, Ting Zhang, Chengwei Zhu et al. · Journal of Cellular and Molecular Medicine · 2020 · 43 citations · Full text

The potential of asiaticoside for TGF-β1/Smad signaling inhibition in prevention and progression of hypoxia-induced pulmonary hypertension

Xiaobing Wang, Wu Wang, Xiaochun Zhu et al. · Life Sciences · 2015 · 38 citations

Inflammation, Pulmonary Arterial Hypertension, Pulmonary Circulation +10